Cassiopea SpA
CASP.SWDrugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
CB-03-01 cream, 1%
Acne Vulgaris
Clascoterone 5% solution
Alopecia, Androgenetic
cortexolone 17α-propionate
Acne Vulgaris
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CB-03-01 cream, 1% | Phase 3 | Acne Vulgaris | - | - |
Clascoterone 5% solution | Phase 3 | Alopecia, Androgenetic | - | - |
cortexolone 17α-propionate | Phase 2 | Acne Vulgaris | - | - |
Frequently asked questions
What is in Cassiopea SpA's drug pipeline?→
CatalystAlert tracks 3 drug candidates in Cassiopea SpA's (CASP.SW) pipeline across Phase 3, Phase 2. Its lead program is CB-03-01 cream, 1% (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Cassiopea SpA's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Cassiopea SpA (CASP.SW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CASP.SW biotech catalysts?→
Add CASP.SW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Cassiopea SpA's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.